TELA Bio (TELA) Market Capitalization (2019 - 2026)

TELA Bio has reported Market Capitalization for 8 years, with the latest figure at $43.1 million in Q2 2026.

• On a quarterly basis, Market Capitalization fell 43.93% year-over-year to $43.1 million in Q2 2026; TTM through Jun 2026 was $43.1 million, a 43.93% decrease from a year earlier, with the FY2025 full-year figure at $52.6 million, down 39.0% from the prior year.
• Market Capitalization was $43.1 million for Q2 2026 at TELA Bio, up from $35.5 million in the prior quarter.
• The five-year high for Market Capitalization was $247.9 million in Q2 2023, with the low at $35.5 million in Q1 2026.
• Average Market Capitalization over 5 years is $121.5 million, with a median of $109.0 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Market Capitalization jumped 142.96% in 2023, then sank 68.08% in 2024.
• Over 5 years, Market Capitalization stood at $220.4 million in 2022, then dropped by 26.43% to $162.2 million in 2023, then sank by 46.87% to $86.1 million in 2024, then plunged by 39.0% to $52.6 million in 2025, then decreased by 18.07% to $43.1 million in 2026.
• The last three Market Capitalization figures came in at $43.1 million (Q2 2026), $35.5 million (Q1 2026), and $52.6 million (Q4 2025), per Business Quant data.